The new system raises several questions for European Patent Convention countries that are not EU members, say Selin Sinem Erciyas, Aysel Korkmaz Yatkın, Zeynep Çağla Üstün and Aysu Eryaşar of Gün + Partners
Aysel Korkmaz Yatkin, Selin Sinem Erciyas, and Aysu Eryaşar of Gün + Partners report that the highly debated concept of plausibility is gaining prominence in Turkish invalidity proceedings
Selin Sinem Erciyas and Aysel Korkmaz Yatkın of Gün + Partners explain the significance of a ruling in Turkey on the validity of second medical use patents granted by the European Patent Office
Selin Sinem Erciyas of Gün + Partners suggests that intellectual property waivers and compulsory licensing are not the answer in developing and accessing vaccines, and explains why governments should be focused on R&D
Selin Sinem Erciyas and Zeynep Çağla Üstün of Gün and Partners discuss an important ruling where a discovery of evidence application played a significant role in fast-tracking a case
